Search by Drug Name or NDC
NDC 57841-1300-01 MOVANTIK 12.5 mg/1 Details
MOVANTIK 12.5 mg/1
MOVANTIK is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RedHill Biopharma Ltd. The primary component is NALOXEGOL OXALATE.
MedlinePlus Drug Summary
Naloxegol is used to treat constipation caused by opiate (narcotic) pain medications in adults with chronic (ongoing) pain that is not caused by cancer. Naloxegol is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the effects of opiate (narcotic) medications.
Related Packages: 57841-1300-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Naloxegol
Product Information
| NDC | 57841-1300 |
|---|---|
| Product ID | 57841-1300_3da484be-32a1-4265-b58e-fa55b7acd59a |
| Associated GPIs | 52580060300320 |
| GCN Sequence Number | 073335 |
| GCN Sequence Number Description | naloxegol oxalate TABLET 12.5 MG ORAL |
| HIC3 | H3Y |
| HIC3 Description | MU-OPIOID RECEPTOR ANTAGONISTS,PERIPHERALLY-ACTING |
| GCN | 37725 |
| HICL Sequence Number | 041686 |
| HICL Sequence Number Description | NALOXEGOL OXALATE |
| Brand/Generic | Brand |
| Proprietary Name | MOVANTIK |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | naloxegol oxalate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 12.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | NALOXEGOL OXALATE |
| Labeler Name | RedHill Biopharma Ltd |
| Pharmaceutical Class | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA204760 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 57841-1300-01 (57841130001)
| NDC Package Code | 57841-1300-1 |
|---|---|
| Billing NDC | 57841130001 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE (57841-1300-1) |
| Marketing Start Date | 2020-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 13.2655 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | MOVANTIK 12.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis